A significant advance in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This crucial malignant suppressor protein is frequently inactivated in various forms of tumors, causing https://tealbookmarks.com/story21914569/mini-antibodies-restore-tumor-suppressor-p53-new-promising-pathway-for-tumor-management